NASDAQ Companies

Deadline is Fast Approaching on Sunday, December 1st, 2024, at 11:59 p.m. ET Shareholders Should Call Their Brokers Today to Ensure […]

WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical […]

– Enhances Aclaris’ pipeline with complementary biologics portfolio –– Expands leadership team with addition of seasoned biotech executives –– Management […]

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and […]

Two patients exceed 14 months on treatment in Phase 2 trialof advanced ovarian cancer Allarity maintains a cash balance of […]

Patient population for the NAVIGATE trial is based on non-invasive tests and clinical criteria utilizing latest treatment guidelines for portal […]

Tembo Tusker is only the 2ndfull electric utility vehicle pick up truck to receive full on road homologation VTA regulatory […]

SAN FRANCISCO and WALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company […]

Steakholder Foods announces commercial milestones with multiple global players highlighting its accelerating growth strategy and transition to revenue-generation; Receives professional […]

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) — Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased […]